US To Argue In High Court Challenge Of Myriad Gene Patents

Law360, New York (April 1, 2013, 4:47 PM EDT) -- The U.S. Supreme Court on Monday greenlighted the federal government's request to participate in oral arguments in the American Civil Liberties Union's challenge to the validity of Myriad Genetics Inc.'s patents on breast cancer genes, ensuring that another critical voice will take aim at Myriad's controversial intellectual property.

The high court said the Solicitor General will have 10 minutes as an amicus curiae to argue the government's position that breast cancer genes isolated by Myriad cannot be patented because they are no different from genes that...
To view the full article, register now.